CD4+ T lymphocyte counts after autologous transplantation in multiple myeloma: A restrospective study

Leukemia and Lymphoma

Volumn 48, Issue 3, 2007, Pages 506-512

  Gorschlüter, Marcus ^a   Glasmacher, Axel ^a   Sarazin, Susann ^a   Hackbarth, Frank ^a   Hoebert, Eckfried ^a   Orlopp, Katjana ^a   Schmidt Wolf, Ingo G H ^a   Mey, Ulrich ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Autologous stem cell transplantation; CD4+ T lymphocytes; Infections; Multiple myeloma

Indexed keywords

ACICLOVIR; COTRIMOXAZOLE; IMMUNOGLOBULIN; MELPHALAN; THALIDOMIDE;

ADULT; AGED; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; AUTOTRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CD4 LYMPHOCYTE COUNT; DRUG MEGADOSE; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIPLE MYELOMA; NEUTROPENIA; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; MALE; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS;

EID: 33947644169     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190601094347     Document Type: Article

References (12)

1. Benson, C. A., Kaplan, J. E., Masur, H., Pau, A. and Holmes, K. K. (2005) Treating opportunistic infections among HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. Clin Infect Dis, 40, p. S131.
2. Cheson, B. D. (1995) Infectious and immunosuppressive complications of purine analog therapy. J Clin Oncol, 13, pp. 2431-2448.
3. Laurenti, L., Piccioni, P., Piccirillo, N., Sora, F., Chiusolo, P. and Garzia, M. (2004) Immune recovery of lymphocyte subsets 6 years after autologous peripheral blood stem cell transplantation (PBSCT) for lymphoproliferative diseases. A comparison between NHL, HD and MM in group of 149 patients. Leuk Lymphoma, 45, pp. 2063-2070.
4. Attal, M., Harousseau, J. L., Stoppa, A. M., Sotto, J. J., Fuzibet, J. G. and Rossi, J. F. (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med, 335, pp. 91-97.
5. Child, J. A., Morgan, G. J., Davies, F. E., Owen, R. G., Bell, S. E. and Hawkins, K. (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med, 348, pp. 1875-1883.
6. Attal, M., Harousseau, J. L., Facon, T., Guilhot, F., Doyen, C. and Fuzibet, J. G. (2003) Single vs. double autologous stem-cell transplantation for multiple myeloma. N Engl J Med, 349, pp. 2495-2502.
7. Goldschmidt, H., Sonneveld, P., Cremer, F. W., van der Holt, B., Westveer, P. and Breitkreutz, I. (2003) Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients. Ann Hematol, 82, pp. 654-659.
8. Dykewicz, C. A. (2001) Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis, 33, pp. 139-144.
9. Harousseau, J. L. (2005) Stem cell transplantation in multiple myeloma (0, 1, or 2). Curr Opin Oncol, 17, pp. 93-98.
10. Douek, D. C., Vescio, R. A., Betts, M. R., Brenchley, J. M., Hill, B. J. and Zhang, L. (2000) Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet, 355, pp. 1875-1881.
11. Rosinski, S. L., McNiece, I. K., Shpall, E. J., Clough, N., Russell, P. and Blunk, B. (2005) Prognostic analysis of pre-transplant peripheral T-cell levels in patients receiving an autologous hematopoietic progenitor-cell transplant. Bone Marrow Transplant, 27, p. 27.
12. Ketterer, N., Espinouse, D., Chomarat, M., Dumontet, C., Moullet, I. and Rieux, C. (1999) Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: Etiology and potential risk factors. Am J Med, 106, pp. 191-197.